Harvard Health Letter

Is hormone therapy safe again?

Several authoritative organizations have issued new guidelines about hormone therapy (HT)—an area that has led to confusion and conflicting guidelines for the past decade. A coalition of 15 medical groups, including the North American Menopause Society, issued a statement declaring that HT is acceptable for short-term use in healthy women with marked menopausal symptoms up to age 59 or within 10 years of menopause. Short-term use in women of that age does not increase the risk for heart attack and stroke, and does relieve symptoms of menopause. However, the U.S. Preventive Services Task Force recommends against long-term use of HT for the purpose of preventing chronic medical conditions, as contrasted with the purpose of treating menopausal symptoms.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »